Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-01

Clinical Trial Update: Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life

View source ↗

Summary

A completed non-interventional observational study evaluated how pramipexole affects quality of life in people with restless legs syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Status: COMPLETED